Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Shareholders Equity (Quarterly): 1.254B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.254B |
| September 30, 2023 | 1.322B |
| June 30, 2023 | 1.420B |
| March 31, 2023 | 1.488B |
| December 31, 2022 | 1.126B |
| September 30, 2022 | 1.184B |
| June 30, 2022 | 405.41M |
| March 31, 2022 | 453.69M |
| December 31, 2021 | 502.03M |
| September 30, 2021 | 518.33M |
| June 30, 2021 | 560.34M |
| Date | Value |
|---|---|
| March 31, 2021 | 584.91M |
| December 31, 2020 | 338.93M |
| September 30, 2020 | 357.26M |
| June 30, 2020 | 371.80M |
| March 31, 2020 | 384.94M |
| December 31, 2019 | 389.92M |
| September 30, 2019 | 162.53M |
| June 30, 2019 | -46.99M |
| March 31, 2019 | -38.76M |
| December 31, 2018 | -29.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-46.99M
Minimum
Jun 2019
1.488B
Maximum
Mar 2023
672.50M
Average
502.03M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 16.49B |
| RayzeBio inc (DELISTED) | 575.32M |
| Icosavax Inc (DELISTED) | 232.38M |
| Madrigal Pharmaceuticals Inc | 405.33M |
| Theseus Pharmaceuticals Inc (DELISTED) | 224.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.336B |
| Total Liabilities (Quarterly) | 81.97M |